Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer

PURPOSE: An open-label Phase 1 study of recombinant prime-boost poxviruses targeting CEA and MUC-1 in patients with advanced pancreatic cancer was conducted to determine safety, tolerability and obtain preliminary data on immune response and survival. PATIENTS AND METHODS: Ten patients with advanced...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kaufman, Howard L, Kim-Schulze, Seunghee, Manson, Kelledy, DeRaffele, Gail, Mitcham, Josephine, Seo, Kang Seok, Kim, Dae Won, Marshall, John
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2007
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2217514/
https://ncbi.nlm.nih.gov/pubmed/18039393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-5-60
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak